| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.607 | 0.004 | 0.826 | Platelet adhesion inhibitor | 0.565 0.004 DBMET00091 0.826 0.002 DBMET00092 0.356 0.018 DBMET00093 0.479 0.006 DBMET00094 0.275 0.041 DBMET00095 0.451 0.008 DBMET00096 0.351 0.019 DBMET00618 0.333 0.024 DBMET01209 0.175 0.085 DBMET01207 | DBMET00092 | |
| 0.552 | 0.009 | 0.651 | Anticonvulsant | 0.651 0.005 DBMET00091 0.249 0.058 DBMET00093 0.369 0.026 DBMET00094 0.187 0.093 DBMET00095 0.189 0.091 DBMET00618 0.476 0.014 DBMET01209 0.151 0.128 DBMET01207 | DBMET00091 | |
| 0.476 | 0.056 | 0.598 | Analgesic | 0.598 0.027 DBMET00091 0.31 0.134 DBMET00093 0.37 0.098 DBMET00096 0.404 0.083 DBMET01209 | DBMET00091 | |
| 0.454 | 0.048 | 0.886 | Antiobesity | 0.58 0.023 DBMET00091 0.368 0.079 DBMET00092 0.524 0.033 DBMET00093 0.274 0.136 DBMET00094 0.545 0.029 DBMET00095 0.886 0.005 DBMET00096 0.279 0.132 DBMET01202 0.238 0.168 DBMET01209 | DBMET00096 | |
| 0.418 | 0.024 | 0.956 | Platelet antagonist | 0.517 0.012 DBMET00091 0.956 0.002 DBMET00092 0.38 0.031 DBMET00093 0.341 0.04 DBMET00094 0.346 0.039 DBMET00095 0.261 0.068 DBMET00096 0.519 0.012 DBMET00618 0.523 0.012 DBMET01202 0.198 0.102 DBMET01209 0.186 0.112 DBMET01207 | DBMET00092 | |
| 0.399 | 0.049 | 0.64 | Antithrombotic | 0.334 0.07 DBMET00091 0.64 0.012 DBMET00092 0.223 0.151 DBMET00093 0.333 0.071 DBMET00094 0.289 0.096 DBMET00095 0.317 0.078 DBMET00618 0.505 0.028 DBMET01202 0.333 0.071 DBMET01209 0.277 0.106 DBMET01207 | DBMET00092 | |
| 0.345 | 0.007 | 0.362 | Alpha 2b adrenoreceptor antagonist | 0.212 0.021 DBMET00091 0.175 0.03 DBMET00093 0.165 0.033 DBMET00094 0.172 0.031 DBMET00095 0.362 0.006 DBMET00096 0.101 0.074 DBMET00618 0.093 0.082 DBMET01208 0.185 0.027 DBMET01209 | DBMET00096 | |
| 0.285 | 0.006 | 0.44 | Dopamine D1 antagonist | 0.335 0.005 DBMET00091 0.1 0.025 DBMET00093 0.096 0.026 DBMET00094 0.088 0.029 DBMET00095 0.44 0.004 DBMET00096 0.085 0.03 DBMET00618 0.109 0.022 DBMET01209 | DBMET00096 | |
| 0.285 | 0.012 | 0.397 | Dopamine antagonist | 0.202 0.018 DBMET00091 0.156 0.025 DBMET00093 0.104 0.037 DBMET00094 0.261 0.014 DBMET00095 0.397 0.008 DBMET00096 0.09 0.042 DBMET01208 0.168 0.023 DBMET01209 | DBMET00096 | |
| 0.275 | 0.009 | 0.423 | Alpha 2 adrenoreceptor antagonist | 0.423 0.005 DBMET00091 0.086 0.059 DBMET00093 0.101 0.047 DBMET00094 0.089 0.056 DBMET00095 0.198 0.018 DBMET00096 0.102 0.047 DBMET01209 | DBMET00091 | |
| 0.28 | 0.018 | 0.28 | 5 Hydroxytryptamine 2 antagonist | 0.192 0.033 DBMET00091 0.164 0.04 DBMET00093 0.086 0.084 DBMET00094 0.211 0.028 DBMET00095 0.251 0.021 DBMET00096 0.156 0.042 DBMET01208 0.227 0.025 DBMET01209 | ||
| 0.294 | 0.037 | 0.906 | Platelet aggregation inhibitor | 0.197 0.083 DBMET00091 0.906 0.003 DBMET00092 0.25 0.051 DBMET01202 | DBMET00092 | |
| 0.252 | 0.009 | 0.329 | Dopamine D4 antagonist | 0.114 0.023 DBMET00091 0.192 0.013 DBMET00093 0.075 0.034 DBMET00094 0.123 0.021 DBMET00095 0.329 0.006 DBMET00096 0.065 0.039 DBMET01208 0.116 0.022 DBMET01209 0.052 0.048 DBMET01207 | DBMET00096 | |
| 0.241 | 0.005 | 0.25 | Purinergic P2 antagonist | 0.229 0.005 DBMET00091 0.171 0.009 DBMET00093 0.133 0.013 DBMET00094 0.219 0.006 DBMET00095 0.058 0.05 DBMET00096 0.11 0.018 DBMET00618 0.187 0.008 DBMET01208 0.25 0.005 DBMET01209 | DBMET01209 | |
| 0.311 | 0.082 | 0.373 | Thyroid hormone beta antagonist | 0.208 0.147 DBMET00091 0.178 0.176 DBMET00094 0.373 0.061 DBMET01209 | DBMET01209 | |
| 0.251 | 0.027 | 0.291 | 3C-like protease (Human coronavirus) inhibitor | 0.252 0.027 DBMET00093 0.286 0.015 DBMET00095 0.176 0.068 DBMET00096 0.162 0.083 DBMET00618 0.291 0.013 DBMET01208 0.265 0.021 DBMET01209 | DBMET01208 | |
| 0.231 | 0.013 | 0.247 | Alpha 2c adrenoreceptor antagonist | 0.247 0.01 DBMET00091 0.098 0.067 DBMET00093 0.118 0.051 DBMET00094 0.084 0.082 DBMET00095 0.205 0.017 DBMET00096 0.117 0.052 DBMET01209 | DBMET00091 | |
| 0.307 | 0.09 | 0.37 | Thyroid hormone antagonist | 0.196 0.166 DBMET00091 0.184 0.175 DBMET01202 0.37 0.066 DBMET01209 | DBMET01209 | |
| 0.237 | 0.022 | 0.291 | Alpha adrenoreceptor antagonist | 0.291 0.016 DBMET00091 0.079 0.072 DBMET00093 0.106 0.053 DBMET00095 0.209 0.026 DBMET00096 0.184 0.03 DBMET01209 | DBMET00091 | |
| 0.224 | 0.015 | 0.362 | Dopamine D2 antagonist | 0.149 0.023 DBMET00091 0.079 0.04 DBMET00094 0.112 0.029 DBMET00095 0.362 0.008 DBMET00096 0.057 0.052 DBMET01208 0.15 0.023 DBMET01209 | DBMET00096 | |
| 0.219 | 0.015 | 0.219 | 5 Hydroxytryptamine 2C antagonist | 0.152 0.026 DBMET00091 0.133 0.031 DBMET00093 0.173 0.021 DBMET00095 0.12 0.036 DBMET01208 0.124 0.034 DBMET01209 | ||
| 0.214 | 0.012 | 0.299 | Alpha 2a adrenoreceptor antagonist | 0.299 0.007 DBMET00091 0.08 0.048 DBMET00094 0.19 0.015 DBMET00096 0.082 0.047 DBMET01209 | DBMET00091 | |
| 0.197 | 0.002 | 0.231 | Glucose-6-phosphate translocase inhibitor | 0.231 0.002 DBMET00091 0.188 0.002 DBMET00093 0.133 0.004 DBMET00094 0.085 0.009 DBMET00095 0.177 0.003 DBMET00096 0.091 0.008 DBMET00618 0.087 0.009 DBMET01208 0.181 0.002 DBMET01209 0.08 0.011 DBMET01207 | DBMET00091 | |
| 0.218 | 0.03 | 0.218 | 5 Hydroxytryptamine antagonist | 0.117 0.066 DBMET00091 0.133 0.057 DBMET00093 0.157 0.047 DBMET00095 0.132 0.058 DBMET00096 0.124 0.062 DBMET01208 0.196 0.035 DBMET01209 | ||
| 0.193 | 0.02 | 0.201 | 5 Hydroxytryptamine 2A antagonist | 0.082 0.058 DBMET00091 0.118 0.038 DBMET00093 0.149 0.029 DBMET00095 0.201 0.019 DBMET00096 0.116 0.039 DBMET01208 0.148 0.029 DBMET01209 | DBMET00096 | |
| 0.2 | 0.042 | 0.2 | Acetylcholine M1 receptor antagonist | 0.143 0.081 DBMET00094 0.139 0.085 DBMET00618 0.134 0.091 DBMET01207 | ||
| 0.315 | 0.164 | 0.412 | MAP kinase 1 inhibitor | 0.266 0.216 DBMET00093 0.412 0.099 DBMET01209 | DBMET01209 | |
| 0.307 | 0.156 | 0.605 | Cyclophilin D inhibitor | 0.605 0.026 DBMET00091 0.429 0.076 DBMET00093 0.415 0.083 DBMET00095 0.419 0.08 DBMET01202 0.245 0.219 DBMET01208 | DBMET00091 | |
| 0.155 | 0.009 | 0.195 | Dopamine D4 agonist | 0.195 0.007 DBMET00091 0.054 0.031 DBMET00093 0.077 0.02 DBMET00094 0.048 0.038 DBMET01209 0.075 0.021 DBMET01207 | DBMET00091 | |
| 0.159 | 0.014 | 0.245 | Dopamine agonist | 0.245 0.007 DBMET00091 0.086 0.034 DBMET00094 | DBMET00091 | |
| 0.231 | 0.088 | 0.253 | Hypoglycemic | 0.214 0.1 DBMET00618 0.253 0.075 DBMET01202 | DBMET01202 | |
| 0.16 | 0.022 | 0.174 | Histamine H1 receptor antagonist | 0.174 0.018 DBMET00091 0.131 0.029 DBMET00093 0.125 0.031 DBMET00094 0.084 0.054 DBMET00095 0.074 0.064 DBMET00096 0.085 0.052 DBMET01208 0.113 0.035 DBMET01209 0.116 0.034 DBMET01207 | DBMET00091 | |
| 0.15 | 0.015 | 0.225 | Dopamine D3 antagonist | 0.08 0.032 DBMET00091 0.074 0.035 DBMET00093 0.064 0.041 DBMET00094 0.083 0.031 DBMET00095 0.225 0.009 DBMET00096 0.086 0.03 DBMET01208 0.055 0.05 DBMET01209 | DBMET00096 | |
| 0.145 | 0.01 | 0.145 | Alpha 2d adrenoreceptor antagonist | 0.112 0.031 DBMET00091 0.138 0.013 DBMET00093 0.09 0.071 DBMET00094 0.139 0.013 DBMET00095 0.115 0.028 DBMET00096 0.112 0.031 DBMET00618 0.133 0.015 DBMET01208 0.126 0.019 DBMET01209 | ||
| 0.172 | 0.047 | 0.424 | Hemostatic | 0.257 0.021 DBMET00091 0.424 0.006 DBMET00092 0.203 0.031 DBMET00096 0.124 0.106 DBMET01209 | DBMET00092 | |
| 0.13 | 0.012 | 0.13 | 5 Hydroxytryptamine 3 antagonist | 0.125 0.013 DBMET00093 0.087 0.021 DBMET00095 0.051 0.047 DBMET00096 0.103 0.017 DBMET01208 0.125 0.013 DBMET01209 | ||
| 0.246 | 0.129 | 0.405 | Prostaglandin dehydrogenase inhibitor | 0.185 0.167 DBMET00091 0.405 0.066 DBMET01209 | DBMET01209 | |
| 0.192 | 0.077 | 0.192 | 5 Hydroxytryptamine 3E antagonist | 0.192 0.077 DBMET00091 0.164 0.157 DBMET00092 0.188 0.086 DBMET00093 0.188 0.085 DBMET00094 0.177 0.114 DBMET00095 0.176 0.117 DBMET01208 0.174 0.122 DBMET01207 | ||
| 0.225 | 0.11 | 0.225 | 5 Hydroxytryptamine uptake stimulant | 0.225 0.11 DBMET00091 0.202 0.148 DBMET00093 0.199 0.153 DBMET00094 0.195 0.162 DBMET00095 0.212 0.13 DBMET00618 0.197 0.158 DBMET01208 0.2 0.152 DBMET01209 0.191 0.17 DBMET01207 | ||
| 0.123 | 0.01 | 0.123 | 5 Hydroxytryptamine 6 antagonist | 0.092 0.018 DBMET00091 0.09 0.018 DBMET00093 0.069 0.03 DBMET00094 0.114 0.011 DBMET00095 0.085 0.02 DBMET01208 0.053 0.044 DBMET01209 | ||
| 0.241 | 0.132 | 0.263 | Cholesterol antagonist | 0.202 0.163 DBMET00093 0.263 0.116 DBMET00618 0.236 0.136 DBMET01202 0.202 0.163 DBMET01209 | DBMET00618 | |
| 0.132 | 0.025 | 0.214 | 5 Hydroxytryptamine agonist | 0.107 0.031 DBMET00091 0.079 0.042 DBMET00093 0.077 0.043 DBMET00095 0.214 0.013 DBMET00096 0.064 0.051 DBMET01208 0.096 0.035 DBMET01209 | DBMET00096 | |
| 0.153 | 0.047 | 0.153 | Pregnane X receptor agonist | 0.15 0.052 DBMET00093 0.149 0.055 DBMET00094 0.15 0.053 DBMET00095 0.147 0.058 DBMET00618 0.151 0.051 DBMET01208 0.144 0.064 DBMET01209 | ||
| 0.119 | 0.014 | 0.128 | Protein kinase C iota inhibitor | 0.128 0.013 DBMET00093 0.083 0.025 DBMET00095 0.067 0.035 DBMET00096 0.098 0.019 DBMET01208 0.096 0.02 DBMET01209 | DBMET00093 | |
| 0.143 | 0.04 | 0.148 | Sphingosine 1-phosphate receptor 4 antagonist | 0.148 0.035 DBMET00091 0.111 0.092 DBMET00093 0.116 0.081 DBMET00094 0.127 0.06 DBMET00095 0.118 0.076 DBMET00618 0.12 0.071 DBMET01202 0.124 0.065 DBMET01208 0.12 0.072 DBMET01209 | DBMET00091 | |
| 0.175 | 0.072 | 0.232 | Tumour necrosis factor antagonist | 0.155 0.095 DBMET00095 0.232 0.037 DBMET01209 | DBMET01209 | |
| 0.121 | 0.021 | 0.121 | 5 Hydroxytryptamine 7 antagonist | 0.062 0.044 DBMET00091 0.058 0.047 DBMET00094 0.062 0.044 DBMET00095 | ||
| 0.107 | 0.008 | 0.156 | Purinergic P2X antagonist | 0.046 0.037 DBMET00091 0.098 0.009 DBMET00093 0.065 0.02 DBMET00094 0.136 0.005 DBMET00095 0.059 0.024 DBMET00618 0.145 0.005 DBMET01208 0.156 0.005 DBMET01209 | DBMET01209 | |
| 0.252 | 0.156 | 0.421 | Beta lactamase inhibitor | 0.421 0.094 DBMET01209 | DBMET01209 | |
| 0.116 | 0.023 | 0.116 | Histamine H2 receptor antagonist | 0.09 0.047 DBMET00091 0.096 0.039 DBMET00093 0.094 0.041 DBMET00094 | ||
| 0.098 | 0.008 | 0.098 | 5 Hydroxytryptamine 2C agonist | 0.073 0.013 DBMET00091 0.088 0.009 DBMET00093 0.068 0.016 DBMET00094 0.064 0.018 DBMET00095 0.057 0.023 DBMET00096 0.064 0.018 DBMET01208 0.086 0.01 DBMET01209 0.063 0.019 DBMET01207 | ||
| 0.109 | 0.022 | 0.109 | Acetylcholine M4 receptor antagonist | 0.087 0.04 DBMET00094 0.072 0.055 DBMET01207 | ||
| 0.103 | 0.018 | 0.115 | Acetylcholine M5 receptor agonist | 0.077 0.037 DBMET00093 0.075 0.039 DBMET00094 0.074 0.04 DBMET00095 0.115 0.013 DBMET01209 | DBMET01209 | |
| 0.121 | 0.037 | 0.121 | Nitric-oxide synthase inhibitor | 0.104 0.054 DBMET00093 | ||
| 0.132 | 0.05 | 0.141 | 5 Hydroxytryptamine 2B antagonist | 0.132 0.05 DBMET00091 0.106 0.076 DBMET00093 0.116 0.065 DBMET00095 0.111 0.07 DBMET01208 0.141 0.045 DBMET01209 | DBMET01209 | |
| 0.093 | 0.013 | 0.096 | Exportin-1 inhibitor | 0.093 0.013 DBMET00093 0.076 0.031 DBMET00094 0.094 0.012 DBMET00095 0.072 0.038 DBMET00096 0.069 0.044 DBMET00618 0.096 0.011 DBMET01208 0.094 0.012 DBMET01209 | DBMET01208 | |
| 0.123 | 0.044 | 0.124 | Acetylcholine release stimulant | 0.108 0.069 DBMET00093 0.1 0.087 DBMET00094 0.124 0.041 DBMET00095 0.111 0.063 DBMET01208 0.105 0.075 DBMET01209 | DBMET00095 | |
| 0.093 | 0.017 | 0.093 | Alpha 2 adrenoreceptor agonist | 0.068 0.033 DBMET00093 | ||
| 0.082 | 0.006 | 0.111 | Purinergic P2T antagonist | 0.111 0.005 DBMET00091 0.023 0.015 DBMET00094 0.021 0.015 DBMET00096 0.021 0.015 DBMET00618 | DBMET00091 | |
| 0.092 | 0.019 | 0.092 | 5 Hydroxytryptamine 3 agonist | 0.063 0.044 DBMET00091 0.079 0.028 DBMET00093 0.067 0.039 DBMET00095 0.061 0.047 DBMET01208 0.063 0.043 DBMET01209 | ||
| 0.078 | 0.008 | 0.097 | Urate transporter 1 inhibitor | 0.097 0.005 DBMET00093 0.057 0.015 DBMET00095 0.074 0.009 DBMET01208 0.073 0.009 DBMET01209 | DBMET00093 | |
| 0.128 | 0.06 | 0.128 | Acetylcholine muscarinic antagonist | 0.107 0.082 DBMET00094 0.108 0.081 DBMET00618 | ||
| 0.089 | 0.022 | 0.089 | Dopamine uptake inhibitor | 0.066 0.033 DBMET00091 0.053 0.045 DBMET00093 0.057 0.041 DBMET00094 0.056 0.042 DBMET00095 0.07 0.03 DBMET00618 0.05 0.049 DBMET01208 0.06 0.038 DBMET01207 | ||
| 0.07 | 0.005 | 0.07 | Nerve growth factor antagonist | 0.065 0.007 DBMET00093 0.047 0.022 DBMET00094 0.068 0.006 DBMET00095 0.041 0.033 DBMET00096 0.042 0.031 DBMET00618 0.056 0.012 DBMET01208 0.07 0.005 DBMET01209 | ||
| 0.093 | 0.03 | 0.122 | Benzodiazepine agonist | 0.087 0.034 DBMET00091 0.063 0.062 DBMET00093 0.076 0.043 DBMET00094 0.072 0.048 DBMET00095 0.122 0.015 DBMET01209 | DBMET01209 | |
| 0.099 | 0.037 | 0.372 | CYP2A6 inhibitor | 0.109 0.032 DBMET00091 0.162 0.013 DBMET00093 0.264 0.004 DBMET00095 0.372 0.003 DBMET01208 | DBMET01208 | |
| 0.099 | 0.038 | 0.102 | Inducible nitric-oxide synthase inhibitor | 0.102 0.035 DBMET00093 0.082 0.059 DBMET01209 | DBMET00093 | |
| 0.064 | 0.004 | 0.064 | Integrin alpha1beta1 antagonist | 0.061 0.004 DBMET00093 0.043 0.015 DBMET00094 0.058 0.005 DBMET00095 0.051 0.007 DBMET00096 0.051 0.007 DBMET00618 0.037 0.031 DBMET01202 0.058 0.005 DBMET01208 0.06 0.004 DBMET01209 | ||
| 0.109 | 0.05 | 0.149 | Antiadrenergic | 0.129 0.042 DBMET00091 0.149 0.036 DBMET00096 | DBMET00096 | |
| 0.107 | 0.05 | 0.147 | Adrenaline antagonist | 0.127 0.041 DBMET00091 0.147 0.035 DBMET00096 | DBMET00096 | |
| 0.138 | 0.083 | 0.169 | Sphingosine 1-phosphate receptor 5 antagonist | 0.15 0.061 DBMET00094 0.169 0.035 DBMET01202 0.124 0.114 DBMET01207 | DBMET01202 | |
| 0.249 | 0.193 | 0.432 | DNA polymerase beta inhibitor | 0.432 0.107 DBMET01209 | DBMET01209 | |
| 0.073 | 0.018 | 0.093 | 5 Hydroxytryptamine 2 agonist | 0.093 0.011 DBMET00091 0.066 0.022 DBMET00093 0.053 0.034 DBMET00095 0.052 0.035 DBMET01208 0.06 0.026 DBMET01209 | DBMET00091 | |
| 0.093 | 0.038 | 0.124 | Caspase 7 inhibitor | 0.106 0.022 DBMET00093 0.083 0.055 DBMET00095 0.096 0.032 DBMET01208 0.124 0.013 DBMET01209 | DBMET01209 | |
| 0.089 | 0.036 | 0.102 | 5 Hydroxytryptamine 1A antagonist | 0.102 0.031 DBMET01209 | DBMET01209 | |
| 0.079 | 0.027 | 0.079 | Adrenaline uptake inhibitor | 0.058 0.046 DBMET00091 0.057 0.049 DBMET00093 0.064 0.041 DBMET00095 0.054 0.052 DBMET00096 0.056 0.049 DBMET01208 | ||
| 0.107 | 0.056 | 0.107 | Gastric antisecretory | 0.106 0.058 DBMET00095 0.097 0.069 DBMET01208 | ||
| 0.085 | 0.034 | 0.085 | Alpha adrenoreceptor agonist | 0.061 0.055 DBMET00093 0.063 0.052 DBMET01209 | ||
| 0.101 | 0.051 | 0.152 | Potassium channel (Voltage-sensitive) activator | 0.152 0.012 DBMET00091 0.104 0.048 DBMET01209 | DBMET00091 | |
| 0.058 | 0.009 | 0.081 | Phenylethanolamine N methyltransferase inhibitor | 0.054 0.011 DBMET00091 0.081 0.004 DBMET00092 0.048 0.016 DBMET00094 0.043 0.024 DBMET00095 0.046 0.019 DBMET00096 0.041 0.027 DBMET00618 0.045 0.02 DBMET01207 | DBMET00092 | |
| 0.082 | 0.033 | 0.092 | 5 Hydroxytryptamine uptake inhibitor | 0.092 0.029 DBMET01207 | DBMET01207 | |
| 0.143 | 0.095 | 0.143 | Heat shock protein 90 alpha antagonist | |||
| 0.092 | 0.043 | 0.167 | Glutamate receptor agonist | 0.167 0.014 DBMET01209 | DBMET01209 | |
| 0.113 | 0.064 | 0.113 | Nav1.5 sodium channel blocker | 0.102 0.082 DBMET00093 0.107 0.073 DBMET00095 0.108 0.071 DBMET01208 0.095 0.094 DBMET01209 | ||
| 0.26 | 0.214 | 0.26 | 5 Hydroxytryptamine release inhibitor | 0.25 0.228 DBMET00618 0.246 0.234 DBMET01208 0.243 0.238 DBMET01209 | ||
| 0.163 | 0.117 | 0.163 | HERG channel blocker | |||
| 0.074 | 0.028 | 0.074 | Acetylcholine M5 receptor antagonist | 0.056 0.048 DBMET00094 | ||
| 0.1 | 0.055 | 0.13 | Antihistaminic | 0.13 0.039 DBMET00091 0.087 0.069 DBMET00094 | DBMET00091 | |
| 0.122 | 0.078 | 0.154 | Antibacterial (Helicobacter pylori) | 0.154 0.043 DBMET00095 0.129 0.069 DBMET00618 0.152 0.044 DBMET01208 | DBMET00095 | |
| 0.053 | 0.01 | 0.053 | Heme oxygenase inhibitor | 0.053 0.01 DBMET00091 0.048 0.016 DBMET00092 0.05 0.013 DBMET00093 0.047 0.018 DBMET00094 0.045 0.022 DBMET00095 0.043 0.03 DBMET00618 0.046 0.02 DBMET01202 0.046 0.021 DBMET01208 0.042 0.033 DBMET01209 0.045 0.022 DBMET01207 | ||
| 0.136 | 0.092 | 0.145 | Heat shock protein 70 antagonist | 0.135 0.095 DBMET00093 0.143 0.064 DBMET00095 0.141 0.073 DBMET00618 0.145 0.057 DBMET01208 0.137 0.088 DBMET01209 | DBMET01208 | |
| 0.282 | 0.239 | 0.282 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.282 0.239 DBMET00091 | ||
| 0.073 | 0.03 | 0.073 | Acetylcholine M3 receptor antagonist | 0.061 0.04 DBMET00618 | ||
| 0.051 | 0.009 | 0.051 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.029 0.019 DBMET00091 0.025 0.024 DBMET00094 0.025 0.023 DBMET01209 | ||
| 0.108 | 0.067 | 0.115 | 5 Hydroxytryptamine 3A agonist | 0.115 0.06 DBMET00093 0.114 0.061 DBMET01209 | DBMET00093 | |
| 0.054 | 0.014 | 0.054 | TRPM8 blocker | 0.051 0.015 DBMET00093 0.043 0.022 DBMET01209 | ||
| 0.093 | 0.053 | 0.125 | Histamine antagonist | 0.125 0.037 DBMET00091 0.076 0.069 DBMET00094 | DBMET00091 | |
| 0.051 | 0.015 | 0.051 | Acid-sensing ion channel blocker | 0.039 0.03 DBMET00091 0.045 0.021 DBMET00094 0.042 0.026 DBMET00618 0.042 0.026 DBMET01207 | ||
| 0.11 | 0.075 | 0.139 | Cholesterol synthesis inhibitor | 0.115 0.07 DBMET00618 0.139 0.051 DBMET01202 | DBMET01202 | |
| 0.043 | 0.008 | 0.065 | Sodium/glucose cotransporter 2 inhibitor | 0.052 0.006 DBMET00091 0.038 0.009 DBMET00093 0.032 0.012 DBMET00095 0.026 0.019 DBMET00096 0.065 0.005 DBMET00618 0.04 0.008 DBMET01208 | DBMET00618 | |
| 0.044 | 0.011 | 0.044 | Endothelial nitric-oxide synthase inhibitor | 0.034 0.018 DBMET00093 | ||
| 0.065 | 0.033 | 0.068 | Potassium channel intermediate-conductance Ca-activated blocker | 0.055 0.054 DBMET00093 0.068 0.029 DBMET01209 | DBMET01209 | |
| 0.063 | 0.031 | 0.063 | Acetylcholine muscarinic agonist | 0.06 0.034 DBMET01207 | ||
| 0.071 | 0.04 | 0.071 | 5 Hydroxytryptamine 1B antagonist | 0.057 0.055 DBMET00091 0.061 0.05 DBMET01209 | ||
| 0.083 | 0.053 | 0.083 | CC chemokine 5 receptor agonist | |||
| 0.077 | 0.047 | 0.078 | Vanilloid 4 agonist | 0.072 0.059 DBMET00095 0.078 0.044 DBMET00618 0.071 0.062 DBMET01208 | DBMET00618 | |
| 0.053 | 0.024 | 0.067 | CC chemokine 4 receptor antagonist | 0.067 0.011 DBMET00091 0.046 0.034 DBMET00093 0.054 0.022 DBMET00094 0.047 0.032 DBMET00095 0.045 0.036 DBMET01208 0.043 0.039 DBMET01209 0.044 0.039 DBMET01207 | DBMET00091 | |
| 0.045 | 0.017 | 0.076 | Purinergic P2X7 antagonist | 0.045 0.017 DBMET00091 0.043 0.019 DBMET00093 0.037 0.023 DBMET00094 0.047 0.016 DBMET00095 0.048 0.015 DBMET01208 0.076 0.006 DBMET01209 | DBMET01209 | |
| 0.123 | 0.095 | 0.278 | Cell wall synthesis inhibitor | 0.13 0.087 DBMET00091 0.152 0.064 DBMET00093 0.177 0.042 DBMET00095 0.114 0.108 DBMET00618 0.278 0.012 DBMET01208 0.198 0.031 DBMET01209 | DBMET01208 | |
| 0.116 | 0.089 | 0.147 | Sodium channel blocker | 0.113 0.092 DBMET00091 0.147 0.06 DBMET00618 | DBMET00618 | |
| 0.093 | 0.066 | 0.123 | Lanosterol 14 alpha demethylase inhibitor | 0.123 0.028 DBMET00091 0.1 0.056 DBMET00093 0.094 0.066 DBMET00095 0.108 0.044 DBMET00618 0.107 0.045 DBMET01202 0.098 0.059 DBMET01208 0.087 0.076 DBMET01209 | DBMET00091 | |
| 0.076 | 0.049 | 0.076 | Rho-associated kinase II inhibitor | |||
| 0.072 | 0.046 | 0.072 | Amidase inhibitor | 0.07 0.048 DBMET00091 | ||
| 0.052 | 0.027 | 0.056 | Dopamine beta hydroxylase inhibitor | 0.054 0.023 DBMET00091 0.052 0.027 DBMET00093 0.055 0.022 DBMET00095 0.056 0.02 DBMET01208 | DBMET01208 | |
| 0.074 | 0.05 | 0.084 | 5 Hydroxytryptamine 1 antagonist | 0.084 0.044 DBMET01209 | DBMET01209 | |
| 0.078 | 0.054 | 0.103 | Alpha 1 adrenoreceptor antagonist | 0.088 0.049 DBMET00096 0.103 0.042 DBMET01209 | DBMET01209 | |
| 0.05 | 0.029 | 0.232 | 5 Hydroxytryptamine 1A agonist | 0.1 0.015 DBMET00095 0.232 0.008 DBMET00096 0.077 0.02 DBMET01208 0.047 0.031 DBMET01209 | DBMET00096 | |
| 0.083 | 0.062 | 0.122 | NMDA receptor antagonist | 0.122 0.034 DBMET00091 0.085 0.059 DBMET00093 0.101 0.046 DBMET01202 0.091 0.053 DBMET01209 | DBMET00091 | |
| 0.053 | 0.033 | 0.158 | Prostaglandin E2 antagonist | 0.078 0.02 DBMET00091 0.046 0.039 DBMET00093 0.102 0.014 DBMET00095 0.05 0.035 DBMET00618 0.158 0.008 DBMET01208 | DBMET01208 | |
| 0.031 | 0.01 | 0.044 | Sodium/glucose cotransporter inhibitor | 0.038 0.008 DBMET00091 0.029 0.012 DBMET00093 0.026 0.017 DBMET00095 0.025 0.02 DBMET00096 0.044 0.006 DBMET00618 0.028 0.013 DBMET01208 | DBMET00618 | |
| 0.074 | 0.055 | 0.074 | Analgesic, opioid | |||
| 0.032 | 0.013 | 0.032 | LFA antagonist | 0.029 0.017 DBMET00095 0.03 0.016 DBMET00618 | ||
| 0.038 | 0.019 | 0.058 | Purinergic P2X3 antagonist | 0.037 0.019 DBMET00093 0.051 0.01 DBMET00095 0.058 0.009 DBMET01208 0.037 0.02 DBMET01209 | DBMET01208 | |
| 0.055 | 0.037 | 0.075 | CC chemokine 2 receptor antagonist | 0.075 0.021 DBMET00091 0.061 0.031 DBMET00094 0.049 0.047 DBMET00618 0.053 0.04 DBMET01207 | DBMET00091 | |
| 0.05 | 0.033 | 0.05 | Squalene epoxidase inhibitor | 0.047 0.04 DBMET00618 0.046 0.044 DBMET01208 | ||
| 0.027 | 0.01 | 0.033 | ICAM 1 antagonist | 0.023 0.017 DBMET00094 0.032 0.005 DBMET00095 0.021 0.02 DBMET00618 0.033 0.005 DBMET01202 0.025 0.012 DBMET01208 | DBMET01202 | |
| 0.081 | 0.064 | 0.088 | Acetylcholine agonist | 0.088 0.057 DBMET00091 | DBMET00091 | |
| 0.026 | 0.011 | 0.029 | Alpha 2d adrenoreceptor agonist | 0.028 0.01 DBMET00093 0.029 0.009 DBMET00095 0.021 0.016 DBMET00096 0.028 0.009 DBMET01208 0.022 0.014 DBMET01209 | DBMET00095 | |
| 0.052 | 0.037 | 0.052 | Dipeptidyl peptidase inhibitor | 0.05 0.043 DBMET01209 | ||
| 0.051 | 0.037 | 0.054 | Phosphodiesterase 7A inhibitor | 0.05 0.04 DBMET00095 0.051 0.039 DBMET01208 0.054 0.032 DBMET01209 | DBMET01209 | |
| 0.049 | 0.034 | 0.052 | CC chemokine receptor 2B antagonist | 0.052 0.027 DBMET00618 | DBMET00618 | |
| 0.044 | 0.029 | 0.044 | Acetylcholine M1 receptor agonist | 0.044 0.029 DBMET01207 | ||
| 0.045 | 0.031 | 0.08 | Purinergic P2Y antagonist | 0.08 0.013 DBMET00091 | DBMET00091 | |
| 0.041 | 0.03 | 0.049 | CC chemokine 3 receptor antagonist | 0.049 0.025 DBMET00094 0.041 0.029 DBMET01202 | DBMET00094 | |
| 0.039 | 0.029 | 0.039 | Glucagon-like peptide 1 receptor antagonist | 0.037 0.036 DBMET00095 0.037 0.035 DBMET01208 0.039 0.029 DBMET01209 | ||
| 0.057 | 0.047 | 0.057 | Acetylcholine M2 receptor antagonist | |||
| 0.052 | 0.043 | 0.072 | Sphingosine kinase 2 inhibitor | 0.072 0.02 DBMET00618 | DBMET00618 | |
| 0.057 | 0.049 | 0.067 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.059 0.044 DBMET00095 0.067 0.031 DBMET01209 | DBMET01209 | |
| 0.176 | 0.168 | 0.176 | Neuropeptide Y2 antagonist | |||
| 0.045 | 0.037 | 0.634 | Sigma receptor antagonist | 0.634 0.004 DBMET00092 0.042 0.04 DBMET01207 | DBMET00092 | |
| 0.016 | 0.01 | 0.016 | NMDA receptor phencyclidine site antagonist | |||
| 0.06 | 0.055 | 0.075 | Sphingosine 1-phosphate receptor 4 agonist | 0.075 0.04 DBMET00091 0.063 0.052 DBMET00095 0.073 0.042 DBMET01202 0.073 0.042 DBMET01208 | DBMET00091 | |
| 0.031 | 0.027 | 0.043 | Gonadotropin-releasing hormone receptor antagonist | 0.043 0.019 DBMET00091 0.033 0.025 DBMET00093 0.03 0.028 DBMET01209 | DBMET00091 | |
| 0.048 | 0.043 | 0.048 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.06 | 0.056 | 0.062 | Bcl2 antagonist | 0.062 0.052 DBMET00091 | DBMET00091 | |
| 0.061 | 0.057 | 0.074 | Alpha 1a adrenoreceptor antagonist | 0.069 0.051 DBMET00096 0.074 0.048 DBMET01209 | DBMET01209 | |
| 0.027 | 0.023 | 0.03 | 5 Hydroxytryptamine 6 agonist | 0.029 0.019 DBMET00091 0.03 0.017 DBMET00093 0.028 0.022 DBMET01208 | DBMET00093 | |
| 0.038 | 0.034 | 0.041 | CF transmembrane conductance regulator antagonist | 0.038 0.036 DBMET00095 0.041 0.024 DBMET00618 | DBMET00618 | |
| 0.03 | 0.027 | 0.032 | Vasopressin 2 antagonist | 0.032 0.024 DBMET00091 | DBMET00091 | |
| 0.101 | 0.098 | 0.135 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.099 DBMET00093 0.133 0.039 DBMET00095 0.135 0.037 DBMET01208 0.132 0.039 DBMET01209 | DBMET01208 | |
| 0.052 | 0.049 | 0.124 | Prostaglandin EP2 antagonist | 0.056 0.045 DBMET00095 0.077 0.028 DBMET00618 0.124 0.014 DBMET01202 | DBMET01202 | |
| 0.021 | 0.019 | 0.044 | Dopamine D1 agonist | 0.044 0.005 DBMET00091 | DBMET00091 | |
| 0.046 | 0.044 | 0.148 | Prostaglandin antagonist | 0.047 0.042 DBMET00091 0.054 0.036 DBMET00095 0.148 0.01 DBMET01202 0.069 0.027 DBMET01208 | DBMET01202 | |
| 0.162 | 0.161 | 0.346 | Cardiotonic | 0.248 0.083 DBMET00091 0.346 0.04 DBMET01202 | DBMET01202 | |
| 0.041 | 0.041 | 0.043 | Dipeptidyl peptidase IV inhibitor | 0.043 0.034 DBMET01209 | DBMET01209 | |
| 0.068 | 0.069 | 0.085 | Potassium channel (Tandem pore domain) blocker | 0.085 0.025 DBMET00091 | DBMET00091 | |
| 0.025 | 0.027 | 0.07 | Prostaglandin EP3 antagonist | 0.07 0.007 DBMET00091 0.039 0.014 DBMET00095 0.03 0.021 DBMET00618 0.047 0.011 DBMET01202 0.043 0.012 DBMET01208 0.027 0.024 DBMET01209 | DBMET00091 | |
| 0.046 | 0.048 | 0.058 | Antiviral (Hepatitis D) | 0.051 0.034 DBMET00093 0.058 0.024 DBMET01209 0.048 0.041 DBMET01207 | DBMET01209 | |
| 0.07 | 0.072 | 0.081 | Sphingosine 1-phosphate receptor antagonist | 0.081 0.043 DBMET01202 | DBMET01202 | |
| 0.059 | 0.063 | 0.075 | Calcium channel P-type blocker | 0.075 0.02 DBMET00094 0.075 0.021 DBMET01207 | DBMET01207 | |
| 0.128 | 0.132 | 0.139 | Ca2+-transporting ATPase inhibitor | 0.139 0.076 DBMET00618 | DBMET00618 | |
| 0.023 | 0.029 | 0.026 | Complement factor 1s inhibitor | 0.025 0.02 DBMET00095 0.026 0.017 DBMET01208 | DBMET01208 | |
| 0.013 | 0.021 | 0.049 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.031 0.009 DBMET00093 0.049 0.006 DBMET01208 | DBMET01208 | |
| 0.019 | 0.027 | 0.023 | Sigma 2 receptor antagonist | 0.023 0.022 DBMET00094 | DBMET00094 | |
| 0.211 | 0.22 | 0.411 | DNA directed DNA polymerase inhibitor | 0.411 0.111 DBMET01209 | DBMET01209 | |
| 0.049 | 0.059 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | 0.064 0.023 DBMET01202 | DBMET01202 | |
| 0.093 | 0.106 | 0.138 | Cell adhesion inhibitor | 0.11 0.074 DBMET00095 0.1 0.09 DBMET00618 0.138 0.054 DBMET01202 | DBMET01202 | |
| 0.101 | 0.115 | 0.108 | Calcium channel blocker | 0.108 0.102 DBMET00094 | DBMET00094 | |
| 0.039 | 0.054 | 0.06 | Cholesterol esterase inhibitor | 0.06 0.017 DBMET01209 | DBMET01209 | |
| 0.015 | 0.03 | 0.044 | Urotensin II antagonist | 0.044 0.007 DBMET00091 | DBMET00091 | |
| 0.027 | 0.043 | 0.064 | Delayed rectifier potassium channel activator | 0.064 0.009 DBMET00091 | DBMET00091 | |
| 0.027 | 0.043 | 0.064 | Potassium channel KCNQ activator | 0.064 0.009 DBMET00091 | DBMET00091 | |
| 0.036 | 0.051 | 0.067 | Glutamate (mGluR group I) agonist | 0.067 0.018 DBMET01209 | DBMET01209 | |
| 0.063 | 0.081 | 0.074 | Orexin receptor 1 antagonist | 0.074 0.045 DBMET01209 | DBMET01209 | |
| 0.135 | 0.153 | 0.15 | Potassium channel (Voltage-sensitive) blocker | 0.15 0.137 DBMET00095 | DBMET00095 | |
| 0.098 | 0.117 | 0.14 | NADPH oxidase inhibitor | 0.14 0.062 DBMET01209 | DBMET01209 | |
| 0.107 | 0.127 | 0.28 | Cholinergic | 0.28 0.022 DBMET01208 0.229 0.035 DBMET01207 | DBMET01208 | |
| 0.04 | 0.061 | 0.054 | Alpha 1d adrenoreceptor antagonist | 0.054 0.046 DBMET01209 | DBMET01209 | |
| 0.131 | 0.154 | 0.199 | Succinate dehydrogenase inhibitor | 0.199 0.05 DBMET01202 0.148 0.117 DBMET01208 | DBMET01202 | |
| 0.013 | 0.036 | 0.037 | Purinergic P2Y12 antagonist | 0.037 0.01 DBMET00091 | DBMET00091 | |
| 0.169 | 0.193 | 0.226 | Hypoxia-inducible factor 1 alpha inhibitor | 0.226 0.122 DBMET00093 0.214 0.136 DBMET01208 | DBMET00093 | |
| 0.02 | 0.044 | 0.028 | Antidiuretic hormone agonist | 0.028 0.018 DBMET00091 | DBMET00091 | |
| 0.048 | 0.072 | 0.063 | Alpha 1b adrenoreceptor antagonist | 0.063 0.058 DBMET01209 | DBMET01209 | |
| 0.039 | 0.063 | 0.061 | Prolyl endopeptidase inhibitor | 0.061 0.023 DBMET01209 | DBMET01209 | |
| 0.05 | 0.076 | 0.066 | Histone deacetylase inhibitor | 0.066 0.045 DBMET01209 | DBMET01209 | |
| 0.025 | 0.052 | 0.942 | Dopamine D5 antagonist | 0.942 0.001 DBMET00096 | DBMET00096 | |
| 0.045 | 0.071 | 0.108 | Cannabinoid CB1 receptor antagonist | 0.108 0.014 DBMET00091 | DBMET00091 | |
| 0.031 | 0.058 | 0.08 | 5 Hydroxytryptamine 1 agonist | 0.061 0.032 DBMET00095 0.08 0.025 DBMET00096 0.048 0.038 DBMET01208 | DBMET00096 | |
| 0.034 | 0.063 | 0.051 | Glutamate (mGluR5) agonist | 0.051 0.024 DBMET01209 | DBMET01209 | |
| 0.023 | 0.053 | 0.033 | Carnitine palmitoyltransferase 1 inhibitor | 0.033 0.026 DBMET00094 | DBMET00094 | |
| 0.128 | 0.158 | 0.178 | Potassium channel blocker | 0.178 0.108 DBMET00091 0.143 0.142 DBMET01208 | DBMET00091 | |
| 0.009 | 0.04 | 0.016 | Vasopressin 2 agonist | 0.016 0.012 DBMET00091 | DBMET00091 | |
| 0.079 | 0.11 | 0.107 | AMP-activated protein kinase stimulant | 0.094 0.079 DBMET00091 0.107 0.061 DBMET00618 | DBMET00618 | |
| 0.053 | 0.085 | 0.084 | Rho-associated kinase I inhibitor | 0.084 0.042 DBMET01208 | DBMET01208 | |
| 0.022 | 0.055 | 0.031 | Carnitine palmitoyltransferase inhibitor | 0.031 0.028 DBMET00094 | DBMET00094 | |
| 0.062 | 0.094 | 0.089 | Cell adhesion molecule inhibitor | 0.083 0.049 DBMET00095 0.089 0.043 DBMET01202 | DBMET01202 | |
| 0.07 | 0.103 | 0.169 | Chemokine receptor antagonist | 0.118 0.049 DBMET00091 0.106 0.058 DBMET00094 0.169 0.025 DBMET01202 | DBMET01202 | |
| 0.007 | 0.044 | 0.023 | Prostaglandin EP1 antagonist | 0.023 0.012 DBMET01208 | DBMET01208 | |
| 0.033 | 0.069 | 0.062 | Farnesyltransferase inhibitor | 0.041 0.04 DBMET00091 0.062 0.019 DBMET01202 0.047 0.031 DBMET01208 | DBMET01202 | |
| 0.029 | 0.066 | 0.037 | 5 Hydroxytryptamine 2B agonist | 0.037 0.031 DBMET00091 | DBMET00091 | |
| 0.073 | 0.111 | 0.097 | Interleukin 1 beta converting enzyme inhibitor | 0.097 0.061 DBMET01208 | DBMET01208 | |
| 0.024 | 0.062 | 0.122 | Factor Xa inhibitor | 0.122 0.01 DBMET00091 | DBMET00091 | |
| 0.053 | 0.093 | 0.098 | CC chemokine receptor antagonist | 0.098 0.036 DBMET00091 0.091 0.041 DBMET00094 0.094 0.039 DBMET01202 0.073 0.059 DBMET01207 | DBMET00091 | |
| 0.037 | 0.077 | 0.443 | Elastase inhibitor | 0.067 0.025 DBMET00092 0.443 0.002 DBMET00096 | DBMET00096 | |
| 0.171 | 0.212 | 0.241 | Vasodilator, peripheral | 0.241 0.134 DBMET01207 | DBMET01207 | |
| 0.187 | 0.228 | 0.246 | 15-Lipoxygenase inhibitor | 0.246 0.168 DBMET01209 | DBMET01209 | |
| 0.065 | 0.107 | 0.213 | HIV-1 integrase (Overall Integration) inhibitor | 0.213 0.009 DBMET01202 0.083 0.074 DBMET01207 | DBMET01202 | |
| 0.087 | 0.128 | 0.215 | Acetylcholinesterase inhibitor | 0.215 0.029 DBMET01208 | DBMET01208 | |
| 0.042 | 0.083 | 0.073 | Sphingosine 1-phosphate receptor 5 agonist | 0.073 0.015 DBMET01202 | DBMET01202 | |
| 0.009 | 0.051 | 0.047 | Prostaglandin D2 antagonist | 0.047 0.007 DBMET01202 | DBMET01202 | |
| 0.082 | 0.124 | 0.105 | Glutamate receptor antagonist | 0.101 0.096 DBMET00093 0.105 0.09 DBMET01209 | DBMET01209 | |
| 0.046 | 0.088 | 0.122 | Cannabinoid receptor antagonist | 0.122 0.021 DBMET00091 | DBMET00091 | |
| 0.035 | 0.079 | 0.055 | Histamine H4 receptor antagonist | 0.055 0.024 DBMET00091 | DBMET00091 | |
| 0.009 | 0.055 | 0.023 | Prostaglandin E2 agonist | 0.023 0.017 DBMET01202 | DBMET01202 | |
| 0.02 | 0.067 | 0.037 | NMDA receptor subunit 3A antagonist | 0.037 0.027 DBMET01202 | DBMET01202 | |
| 0.014 | 0.066 | 0.03 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.03 0.004 DBMET00096 0.021 0.013 DBMET01209 | DBMET00096 | |
| 0.06 | 0.113 | 0.076 | GABA B receptor agonist | 0.07 0.068 DBMET00618 0.076 0.051 DBMET01202 | DBMET01202 | |
| 0.187 | 0.241 | 0.284 | Transcription factor inhibitor | 0.284 0.164 DBMET01209 | DBMET01209 | |
| 0.111 | 0.166 | 0.153 | MAP kinase 3 inhibitor | 0.153 0.062 DBMET01209 | DBMET01209 | |
| 0.033 | 0.089 | 0.054 | Nicotinic alpha7 receptor agonist | 0.054 0.037 DBMET01208 | DBMET01208 | |
| 0.075 | 0.133 | 0.109 | Nav1.3 sodium channel blocker | 0.109 0.087 DBMET00091 | DBMET00091 | |
| 0.025 | 0.084 | 0.037 | AMPA 4 receptor antagonist | 0.037 0.033 DBMET01202 | DBMET01202 | |
| 0.013 | 0.073 | 0.033 | Prostaglandin agonist | 0.033 0.018 DBMET01202 | DBMET01202 | |
| 0.024 | 0.084 | 0.042 | NMDA receptor subunit 3B antagonist | 0.042 0.032 DBMET01202 | DBMET01202 | |
| 0.009 | 0.07 | 0.131 | Nociceptin (N/OFQ) receptor antagonist | 0.131 0.005 DBMET00091 | DBMET00091 | |
| 0.139 | 0.202 | 0.158 | MAP kinase kinase 5 inhibitor | 0.158 0.123 DBMET00095 0.158 0.122 DBMET01208 | DBMET01208 | |
| 0.06 | 0.124 | 0.187 | Potassium channel activator | 0.187 0.011 DBMET00091 | DBMET00091 | |
| 0.038 | 0.102 | 0.077 | Glucosylceramidase inhibitor | 0.077 0.017 DBMET00618 | DBMET00618 | |
| 0.026 | 0.091 | 0.083 | Thromboxane antagonist | 0.083 0.019 DBMET01202 | DBMET01202 | |
| 0.043 | 0.111 | 0.123 | CXC chemokine receptor antagonist | 0.123 0.016 DBMET01202 | DBMET01202 | |
| 0.028 | 0.096 | 0.094 | Potassium channel small-conductance Ca-activated blocker | 0.043 0.034 DBMET00093 0.042 0.036 DBMET00095 0.094 0.007 DBMET01208 | DBMET01208 | |
| 0.022 | 0.091 | 0.075 | Thromboxane A2 antagonist | 0.075 0.018 DBMET01202 | DBMET01202 | |
| 0.073 | 0.144 | 0.094 | Glutamate (mGluR7) agonist | 0.094 0.074 DBMET01202 | DBMET01202 | |
| 0.051 | 0.125 | 0.068 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.058 DBMET01202 | DBMET01202 | |
| 0.065 | 0.14 | 0.102 | Protein kinase C zeta inhibitor | 0.097 0.054 DBMET00093 0.102 0.048 DBMET01208 | DBMET01208 | |
| 0.147 | 0.225 | 0.225 | Thioredoxin glutathione reductase inhibitor | 0.225 0.152 DBMET01209 | DBMET01209 | |
| 0.126 | 0.206 | 0.174 | Streptokinase A inhibitor | 0.174 0.151 DBMET01209 | DBMET01209 | |
| 0.134 | 0.214 | 0.198 | 5 Hydroxytryptamine release stimulant | 0.163 0.162 DBMET00094 0.198 0.123 DBMET01207 | DBMET01207 | |
| 0.082 | 0.164 | 0.143 | Cytidine deaminase inhibitor | 0.143 0.081 DBMET01209 | DBMET01209 | |
| 0.023 | 0.108 | 0.065 | CC chemokine 5 receptor antagonist | 0.064 0.023 DBMET00094 0.065 0.022 DBMET01202 0.055 0.03 DBMET01207 | DBMET01202 | |
| 0.046 | 0.133 | 0.091 | MAP kinase kinase 8 inhibitor | 0.073 0.041 DBMET00093 0.091 0.027 DBMET01208 | DBMET01208 | |
| 0.067 | 0.158 | 0.088 | Glutamate release inhibitor | 0.088 0.068 DBMET00091 | DBMET00091 | |
| 0.027 | 0.118 | 0.062 | Glutamate (mGluR) agonist | 0.062 0.043 DBMET01209 | DBMET01209 | |
| 0.047 | 0.139 | 0.089 | Protein kinase (CK2) inhibitor | 0.089 0.074 DBMET01208 | DBMET01208 | |
| 0.013 | 0.107 | 0.036 | Integrin antagonist | 0.036 0.033 DBMET01202 | DBMET01202 | |
| 0.059 | 0.154 | 0.085 | DNA directed RNA polymerase inhibitor | 0.085 0.076 DBMET01208 | DBMET01208 | |
| 0.11 | 0.206 | 0.458 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.403 0.015 DBMET00095 0.458 0.01 DBMET01208 | DBMET01208 | |
| 0.005 | 0.105 | 0.016 | Sodium/hydrogen exchanger inhibitor | 0.016 0.014 DBMET00091 | DBMET00091 | |
| 0.046 | 0.147 | 0.069 | Glutamate (mGluR6) antagonist | 0.069 0.042 DBMET00091 0.062 0.061 DBMET01202 | DBMET00091 | |
| 0.005 | 0.106 | 0.024 | Prostaglandin H2 antagonist | 0.024 0.019 DBMET01202 | DBMET01202 | |
| 0.042 | 0.145 | 0.141 | Potassium channel (Ca-activated) activator | 0.141 0.031 DBMET00091 0.089 0.065 DBMET01208 | DBMET00091 | |
| 0.135 | 0.24 | 0.169 | RNA-directed DNA polymerase inhibitor | 0.169 0.154 DBMET00618 | DBMET00618 | |
| 0.15 | 0.256 | 0.185 | Tyrosine 3 hydroxylase inhibitor | 0.185 0.166 DBMET01202 | DBMET01202 | |
| 0.017 | 0.124 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.037 0.021 DBMET00091 | DBMET00091 | |
| 0.043 | 0.149 | 0.076 | Macrophage migration inhibitory factor inhibitor | 0.076 0.056 DBMET01209 | DBMET01209 | |
| 0.018 | 0.129 | 0.027 | Vasopressin 1A agonist | 0.027 0.026 DBMET00091 | DBMET00091 | |
| 0.098 | 0.213 | 0.175 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.175 0.117 DBMET01209 | DBMET01209 | |
| 0.01 | 0.126 | 0.021 | Potassium channel (Inward rectifier) 11 blocker | 0.021 0.008 DBMET00091 | DBMET00091 | |
| 0.021 | 0.139 | 0.042 | Glutamate (mGluR8) antagonist | 0.042 0.015 DBMET01202 | DBMET01202 | |
| 0.067 | 0.187 | 0.372 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.13 0.077 DBMET00093 0.274 0.024 DBMET00095 0.372 0.008 DBMET01208 | DBMET01208 | |
| 0.042 | 0.163 | 0.213 | Butyrylcholinesterase inhibitor | 0.213 0.019 DBMET01208 | DBMET01208 | |
| 0.14 | 0.262 | 0.183 | Transcription factor STAT inhibitor | 0.183 0.164 DBMET01209 | DBMET01209 | |
| 0.082 | 0.207 | 0.133 | Hexokinase inhibitor | 0.122 0.115 DBMET00618 0.131 0.102 DBMET01208 0.133 0.1 DBMET01209 | DBMET01209 | |
| 0.094 | 0.22 | 0.135 | Interferon gamma antagonist | 0.135 0.101 DBMET00618 | DBMET00618 | |
| 0.143 | 0.271 | 0.214 | Alpha-glucosidase inhibitor | 0.214 0.21 DBMET01209 | DBMET01209 | |
| 0.025 | 0.156 | 0.123 | 5 Hydroxytryptamine 1F antagonist | 0.123 0.023 DBMET00095 0.109 0.027 DBMET01208 | DBMET00095 | |
| 0.042 | 0.178 | 0.097 | Protein kinase (CK2) alpha inhibitor | 0.097 0.079 DBMET01208 | DBMET01208 | |
| 0.072 | 0.21 | 0.529 | Anticoagulant | 0.529 0.008 DBMET00091 | DBMET00091 | |
| 0.118 | 0.256 | 0.159 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.128 DBMET00618 | DBMET00618 | |
| 0.038 | 0.177 | 0.077 | HIV-1 integrase inhibitor | 0.065 0.056 DBMET01208 0.077 0.041 DBMET01209 | DBMET01209 | |
| 0.015 | 0.156 | 0.062 | Glutamate (mGluR3) antagonist | 0.062 0.008 DBMET01202 | DBMET01202 | |
| 0.031 | 0.18 | 0.07 | MAP3K7 inhibitor | 0.07 0.055 DBMET01208 | DBMET01208 | |
| 0.015 | 0.165 | 0.035 | Carboxypeptidase B inhibitor | 0.035 0.019 DBMET01202 | DBMET01202 | |
| 0.069 | 0.219 | 0.747 | Neurotrophic factor | 0.747 0.002 DBMET00094 | DBMET00094 | |
| 0.041 | 0.191 | 0.083 | Pim-1 kinase inhibitor | 0.083 0.077 DBMET01208 | DBMET01208 | |
| 0.023 | 0.176 | 0.065 | NMDA 2B receptor antagonist | 0.06 0.031 DBMET00091 0.051 0.041 DBMET00093 0.065 0.028 DBMET01208 | DBMET01208 | |
| 0.005 | 0.159 | 0.202 | Factor X inhibitor | 0.202 0.005 DBMET00091 | DBMET00091 | |
| 0.055 | 0.21 | 0.116 | M17 leucyl aminopeptidase inhibitor | 0.11 0.088 DBMET01202 0.116 0.081 DBMET01209 | DBMET01209 | |
| 0.004 | 0.159 | 0.039 | Arginase inhibitor | 0.039 0.023 DBMET01202 | DBMET01202 | |
| 0.012 | 0.167 | 0.044 | Phosphorylase inhibitor | 0.044 0.034 DBMET00091 | DBMET00091 | |
| 0.011 | 0.17 | 0.041 | Geranyltranstransferase inhibitor | 0.041 0.035 DBMET01208 | DBMET01208 | |
| 0.046 | 0.216 | 0.085 | MDM2 inhibitor | 0.085 0.014 DBMET01202 | DBMET01202 | |
| 0.007 | 0.179 | 0.025 | Lysine carboxypeptidase inhibitor | 0.025 0.021 DBMET01202 | DBMET01202 | |
| 0.054 | 0.226 | 0.428 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.385 0.02 DBMET00095 0.428 0.013 DBMET01208 | DBMET01208 | |
| 0.007 | 0.18 | 0.018 | Integrin alphaVbeta1 antagonist | 0.018 0.015 DBMET01202 | DBMET01202 | |
| 0.07 | 0.249 | 0.184 | LIM domain kinase 1 inhibitor | 0.184 0.071 DBMET01208 | DBMET01208 | |
| 0.049 | 0.233 | 0.098 | Caspase 3 inhibitor | 0.098 0.095 DBMET01209 | DBMET01209 | |
| 0.06 | 0.249 | 0.252 | Protein kinase (CK1) gamma 1 inhibitor | 0.202 0.042 DBMET00095 0.252 0.028 DBMET01208 | DBMET01208 | |
| 0.017 | 0.206 | 0.062 | Nicotinic acid receptor 1 agonist | 0.062 0.015 DBMET00091 | DBMET00091 | |
| 0.033 | 0.223 | 0.418 | Potassium channel large-conductance Ca-activated activator | 0.418 0.004 DBMET00091 | DBMET00091 | |
| 0.062 | 0.257 | 0.134 | Dual specificity phosphatase 3 inhibitor | 0.134 0.112 DBMET01202 | DBMET01202 | |
| 0.04 | 0.239 | 0.111 | GABA C receptor agonist | 0.111 0.056 DBMET01202 | DBMET01202 | |
| 0.015 | 0.215 | 0.072 | p53 inhibitor | 0.072 0.005 DBMET01202 | DBMET01202 | |
| 0.021 | 0.23 | 0.061 | Check point kinase 1 inhibitor | 0.061 0.058 DBMET01208 | DBMET01208 | |
| 0.025 | 0.234 | 0.07 | Aminopeptidase I inhibitor | 0.07 0.053 DBMET01202 | DBMET01202 | |
| 0.012 | 0.229 | 0.045 | Aldose reductase inhibitor | 0.045 0.044 DBMET01202 | DBMET01202 | |
| 0.025 | 0.246 | 0.112 | Potassium channel (Ca-activated) blocker | 0.068 0.03 DBMET00095 0.112 0.007 DBMET01208 | DBMET01208 | |
| 0.096 | 0.318 | 0.154 | Catenin beta inhibitor | 0.154 0.096 DBMET01209 | DBMET01209 | |
| 0.007 | 0.232 | 0.051 | Protocollagen prolyl hydroxylase inhibitor | 0.051 0.005 DBMET01207 | DBMET01207 | |
| 0.034 | 0.261 | 0.093 | Viral attachment inhibitor | 0.072 0.069 DBMET00094 0.093 0.029 DBMET01202 0.074 0.065 DBMET01207 | DBMET01202 | |
| 0.004 | 0.233 | 0.019 | Free fatty acid receptor 1 agonist | 0.019 0.011 DBMET01202 | DBMET01202 | |
| 0.076 | 0.309 | 0.42 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.235 0.069 DBMET00093 0.249 0.061 DBMET00095 0.42 0.011 DBMET01208 | DBMET01208 | |
| 0.032 | 0.265 | 0.096 | MAP kinase 8 inhibitor | 0.096 0.064 DBMET01208 | DBMET01208 | |
| 0.024 | 0.258 | 0.062 | Prostaglandin F2 alpha antagonist | 0.062 0.042 DBMET01202 | DBMET01202 | |
| 0.058 | 0.296 | 0.13 | Arachidonic acid antagonist | 0.13 0.113 DBMET01202 | DBMET01202 | |
| 0.011 | 0.253 | 0.059 | Neutrophil collagenase inhibitor | 0.059 0.052 DBMET01202 | DBMET01202 | |
| 0.058 | 0.302 | 0.198 | Amyloid beta precursor protein antagonist | 0.198 0.059 DBMET01209 | DBMET01209 | |
| 0.113 | 0.37 | 0.279 | Antibacterial | 0.215 0.212 DBMET00618 0.279 0.151 DBMET01202 | DBMET01202 | |
| 0.021 | 0.281 | 0.071 | Topoisomerase II alpha inhibitor | 0.071 0.06 DBMET00091 | DBMET00091 | |
| 0.066 | 0.331 | 0.396 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.139 0.123 DBMET00093 0.202 0.074 DBMET00095 0.396 0.018 DBMET01208 | DBMET01208 | |
| 0.063 | 0.329 | 0.172 | Polo-like kinase-3 inhibitor | 0.145 0.09 DBMET00095 0.172 0.064 DBMET01208 | DBMET01208 | |
| 0.004 | 0.273 | 0.536 | Estrogen receptor beta agonist | 0.536 0.003 DBMET01207 | DBMET01207 | |
| 0.042 | 0.317 | 0.128 | Toll-Like receptor 4 antagonist | 0.128 0.036 DBMET01202 | DBMET01202 | |
| 0.048 | 0.329 | 0.13 | Dual specificity phosphatase inhibitor | 0.13 0.12 DBMET01202 | DBMET01202 | |
| 0.032 | 0.314 | 0.175 | Mucolytic | 0.175 0.02 DBMET01202 | DBMET01202 | |
| 0.003 | 0.286 | 0.91 | Estrogen receptor alpha agonist | 0.91 0.001 DBMET01207 | DBMET01207 | |
| 0.023 | 0.307 | 0.15 | Expectorant | 0.15 0.035 DBMET01202 | DBMET01202 | |
| 0.028 | 0.316 | 0.147 | Vascular endothelial growth factor 3 antagonist | 0.147 0.068 DBMET01208 | DBMET01208 | |
| 0.024 | 0.315 | 0.106 | Ca(v)2.2 blocker | 0.106 0.044 DBMET00091 | DBMET00091 | |
| 0.012 | 0.304 | 0.037 | Purinergic P2Y2 antagonist | 0.037 0.019 DBMET01208 | DBMET01208 | |
| 0.029 | 0.338 | 0.166 | Protein kinase (CK1) gamma inhibitor | 0.143 0.072 DBMET00095 0.166 0.059 DBMET01208 | DBMET01208 | |
| 0.031 | 0.352 | 0.154 | Protein kinase (CK1) gamma 2 inhibitor | 0.121 0.065 DBMET00095 0.154 0.047 DBMET01208 | DBMET01208 | |
| 0.014 | 0.337 | 0.131 | Angiotensin-converting enzyme inhibitor | 0.131 0.006 DBMET01202 | DBMET01202 | |
| 0.033 | 0.358 | 0.24 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.181 0.052 DBMET00093 0.24 0.028 DBMET01208 | DBMET01208 | |
| 0.078 | 0.415 | 0.194 | MAP-kinase-activated kinase 5 inhibitor | 0.194 0.111 DBMET00093 0.168 0.152 DBMET01208 | DBMET00093 | |
| 0.003 | 0.344 | 0.328 | Aminopeptidase P inhibitor | 0.328 0.001 DBMET01202 | DBMET01202 | |
| 0.009 | 0.355 | 0.093 | Peroxisome proliferator-activated receptor gamma agonist | 0.093 0.032 DBMET01202 | DBMET01202 | |
| 0.021 | 0.371 | 0.116 | Vascular endothelial growth factor 1 antagonist | 0.116 0.057 DBMET01208 | DBMET01208 | |
| 0.018 | 0.37 | 0.127 | Protein kinase (CK1) inhibitor | 0.127 0.086 DBMET01208 | DBMET01208 | |
| 0.018 | 0.377 | 0.106 | Protein-tyrosine kinase Lyn inhibitor | 0.106 0.096 DBMET01208 | DBMET01208 | |
| 0.019 | 0.385 | 0.092 | Factor IXa inhibitor | 0.092 0.012 DBMET00091 | DBMET00091 | |
| 0.049 | 0.418 | 0.718 | Tumour necrosis factor alpha release inhibitor | 0.275 0.063 DBMET00096 0.718 0.005 DBMET00618 | DBMET00618 | |
| 0.023 | 0.399 | 0.139 | CDC-like kinase 4 inhibitor | 0.139 0.109 DBMET01208 | DBMET01208 | |
| 0.115 | 0.495 | 0.409 | MAP kinase kinase 6 inhibitor | 0.409 0.053 DBMET00095 0.404 0.056 DBMET01208 | DBMET00095 | |
| 0.005 | 0.411 | 0.831 | Estrogen agonist | 0.831 0.002 DBMET01207 | DBMET01207 | |
| 0.011 | 0.421 | 0.051 | Potassium channel Kv1.5 blocker | 0.051 0.048 DBMET01208 | DBMET01208 | |
| 0.026 | 0.451 | 0.147 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.147 0.097 DBMET01208 | DBMET01208 | |
| 0.029 | 0.455 | 0.172 | Death-associated protein kinase 3 inhibitor | 0.172 0.094 DBMET01208 | DBMET01208 | |
| 0.111 | 0.542 | 0.284 | MAP kinase kinase 3 inhibitor | 0.282 0.012 DBMET00095 0.284 0.011 DBMET01208 | DBMET01208 | |
| 0.007 | 0.455 | 0.038 | Integrin alpha5beta1 antagonist | 0.038 0.033 DBMET01202 | DBMET01202 | |
| 0.006 | 0.457 | 0.061 | HIV-1 integrase (Strand Transfer) inhibitor | 0.061 0.041 DBMET01202 | DBMET01202 | |
| 0.007 | 0.481 | 0.189 | Endothelin-converting enzyme inhibitor | 0.189 0.005 DBMET01202 | DBMET01202 | |
| 0.065 | 0.552 | 0.199 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.199 0.158 DBMET01208 | DBMET01208 | |
| 0.002 | 0.502 | 0.047 | Neutral endopeptidase inhibitor | 0.047 0.008 DBMET01202 | DBMET01202 | |
| 0.004 | 0.515 | 0.041 | Secretase gamma inhibitor | 0.041 0.031 DBMET00091 | DBMET00091 | |
| 0.027 | 0.57 | 0.269 | Insulin secretagoues | 0.269 0.016 DBMET00091 | DBMET00091 | |
| 0.008 | 0.569 | 0.238 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.238 0.073 DBMET01208 | DBMET01208 | |
| 0.009 | 0.573 | 0.246 | Dyrk kinase inhibitor | 0.246 0.074 DBMET01208 | DBMET01208 | |
| 0.01 | 0.577 | 0.085 | Protein kinase C delta inhibitor | 0.085 0.07 DBMET01208 | DBMET01208 | |
| 0.011 | 0.628 | 0.094 | Transforming growth factor antagonist | 0.094 0.024 DBMET01208 | DBMET01208 | |
| 0.005 | 0.625 | 0.058 | HIV-1 integrase (3'-Processing) inhibitor | 0.058 0.049 DBMET01202 | DBMET01202 | |
| 0.008 | 0.65 | 0.142 | Myc inhibitor | 0.142 0.004 DBMET00095 0.139 0.005 DBMET01208 | DBMET00095 | |
| 0.002 | 0.736 | 0.024 | Estrone sulfatase inhibitor | 0.024 0.013 DBMET00094 | DBMET00094 | |
| 0.045 | 0.862 | 0.203 | Interleukin 2 agonist | 0.203 0.184 DBMET01202 | DBMET01202 | |
| 0.003 | 0.899 | 0.056 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.056 0.008 DBMET01202 | DBMET01202 | |
| 0.022 | 0.922 | 0.281 | Sodium/bile acid cotransporter inhibitor | 0.281 0.096 DBMET01202 | DBMET01202 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |